leadf
logo-loader
viewEmerald Health Therapeutics Inc

Emerald Health Therapeutics positioning itself for 'Cannabis 2.0'

Emerald Health Therapeutics Inc (TSXV:EMH) (OTCQX:EMHTF) Vice President Bernie Hertel tells Proactive Investors the Vancouver-based cannabis company is positioning itself for 'Cannabis 2.0', the 17 October 2019 date where regulations change in Canada, and edibles, infused beverages, topicals, concentrates, and vapes will be officially available for sale in mid-December.

Hertel says while the company hasn't disclosed what their product line will look like, the company is 'working behind the scenes' to deliver new products. The company recently received its processing license from Health Canada for its greenhouse facility at its 50%-owned joint venture, Pure Sunfarms.

Quick facts: Emerald Health Therapeutics Inc

Price: 0.185 CAD

TSX-V:EMH
Market: TSX-V
Market Cap: $37.69 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

XPhyto Therapeutics provides update on their oral film drug delivery...

XPhyto Therapeutics (CSE: XPHY-OTC: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive to provide a look at their German subsidiary, Vektor Pharma who is currently advancing two sublingual ODF development programs for the delivery of the active pharmaceutical ingredients. Rogers...

19 minutes ago

2 min read